SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001468429-15-000004
Filing Date
2015-05-19
Accepted
2015-05-19 09:22:49
Documents
1
Period of Report
2013-01-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2111
  Complete submission text file 0001468429-15-000004.txt   3806
Mailing Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243
Business Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243 972-386-7350
Endocan Corporation. (Issuer) CIK: 0000054424 (see all company filings)

IRS No.: 900156146 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 4813 Telephone Communications (No Radiotelephone)

Mailing Address 1754 WILLARD STREET NW, UNIT 3 WASHINGTON DC 20009
Business Address
JOHNSON CHAD STEVEN (Reporting) CIK: 0001600255 (see all company filings)

Type: 3 | Act: 34 | File No.: 002-41703 | Film No.: 15875162